Donath Damian
Donath Damian
The rapid evolution of viral pathogens presents significant challenges for global health, as traditional methods for virus detection often fail to identify novel or genetically diverse viruses. The emergence and reemergence of viral pathoge...
COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions [0.03%]
新冠肺炎：粒细胞的免疫作用及治疗潜力
Zahra Farjami,Mina Moradi,Neshat Ebrahimi et al.
Zahra Farjami et al.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including n...
Evaluating the Immunological Properties of Recombinant Hepatitis B Surface Antigen Using a Multitiered In Vivo and In Vitro Approach [0.03%]
采用多级体内和体外方法评估重组乙型肝炎病毒表面抗原的免疫学特性
Xuan Zhao,Tianshu Shao,Wendong Li et al.
Xuan Zhao et al.
The immunological properties of recombinant hepatitis B surface antigen (rHBsAg), prepared using yeast (Saccharomyces cerevisiae [SC]) and Chinese hamster ovary (CHO) cells, were evaluated through in vitro and in vivo assays to support the ...
NK Cells Were Activated and Involved in the Physiopathology of Hemorrhagic Fever with Renal Syndrome [0.03%]
自然杀伤细胞在汉坦病毒引起肾综合征出血热发病机制中的作用研究进展
Huanjun Shen,Pingzhong Wang,Xiaofei Yang et al.
Huanjun Shen et al.
As a key component of innate immunity, natural killer (NK) cells initiate rapid effector responses against various viral pathogens. However, their role in the pathogenesis of hemorrhagic fever with renal syndrome (HFRS) remains unclear. In ...
Elevated Levels of Serum Interleukin-37 in Chronic Hepatitis B in Comparison with the Spontaneously Cleared and Healthy Control Groups [0.03%]
慢性乙肝患者血清中白细胞介素-37水平升高与自发清除组和健康对照组相比
Soolmaz Khansalar,Erfan Rostami,Aida Khademolhosseini et al.
Soolmaz Khansalar et al.
Background: Interleukin-37 (IL-37) can prevent liver damage and may be an important candidate for use as a novel therapeutic tool in hepatitis B virus (HBV) infection. This study aimed to evaluate the serum levels of IL-37 in individuals wi...
Immunogenic Response Assessment of Hepatitis Delta Virus Antigen from Pakistani Isolate in Rabbits Using a Prokaryotic Expression System [0.03%]
利用原核表达系统评价巴基斯坦地区一例乙型肝炎病毒免疫原性反应
Hifza Manzoor,Muhammad Shahid,Nadeem Ahmed et al.
Hifza Manzoor et al.
The hepatitis delta virus (HDV) is a defective and small, blood-borne viroid-like pathogen that coinfects with the hepatitis B virus (HBV) in about 5% of the infected individuals as it is a satellite virus of HBV. The treatment of HDV infec...
Antibody Development Strategies for SFTSV: From Hybridoma to Emerging Technologies [0.03%]
对SFTSV的抗体开发策略：从杂交瘤技术到新兴技术
Wanqing Lu,Yan Liu,Boyu Zhang et al.
Wanqing Lu et al.
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging zoonotic disease caused by the tick-borne SFTS virus (SFTSV), with a case fatality rate of 16.2-32.6% in East Asia. Currently, no approved vaccines or antiviral treatments ex...
Humoral Immune Response to Inactivated SARS-CoV-2 Vaccine in Populations With and Without Prior COVID-19 Infection: A Longitudinal Cohort Study [0.03%]
针对以前感染和未感染新冠肺炎人群的灭活新冠病毒疫苗体液免疫反应：纵向队列研究
Shuang Zhang,Xiaoman Jiang,Changhui Du et al.
Shuang Zhang et al.
To assess the dynamics of humoral immune responses to inactivated SARS-CoV-2 vaccines across populations with and without prior COVID-19 infection, a longitudinal cohort study was conducted. A total of 38 COVID-19-recovered individuals and ...
Serum Galectin-3 in Hepatitis B e-Antigen-Negative Chronic Hepatitis B Virus Infection: Clinical and Histological Correlations [0.03%]
乙型肝炎e抗原阴性慢性HBV感染患者血清半乳糖凝集素-3的临床及病理意义研究
Yıldız Garip Bilen,Erdem Akbal
Yıldız Garip Bilen
Background and aims: Chronic hepatitis B (CHB) drives liver fibrosis, contributing to chronic liver disease. Galectin-3 (Gal-3), a lectin linked to inflammation and fibrosis, was investigated for its association with liver injury severity i...
Clinical Characteristics of Influenza Pneumonia in Patients with Lung Adenocarcinoma Receiving Immunotherapy [0.03%]
免疫治疗的肺腺癌患者发生流感肺炎的临床特征分析
Weiyi Li,Dan Zhang,Haitong Feng et al.
Weiyi Li et al.
The objective of this study is to examine the general characteristics, clinical manifestations, laboratory findings, and imaging features of patients with lung adenocarcinoma who develop influenza pneumonia while undergoing immunotherapy. A...